Table 1: Characteristics and BIRADS score of the 38 selected patients with ultrasound and digital mammography findings classified as BIRADS 3, 4 or 5. DM microcalc: presence of suspicious microcalcifications on digital mammography; HISTO: histology; n/a: not available.

MX BIRADS

US IRADS

MRI BIRADS

Histology

MX micro

US Size (mm)

MRI 1 Lesion (mm)

MRI 2 Lesion (mm)

MRI 3 Lesion (mm)

Histo 1 Lesion (mm)

Histo 2 Lesion (mm)

Histo 3 Lesion (mm)

1

3

5

IDC + DCIS

 

7

60

32

7

58

28

7

4

4

4

IDC

 

15

50

 

 

50

 

 

3

1

4

Intracystic papillary cancer

X

no

15

8

 

15

10

 

4

4

5

IDC

X

25

80

 

 

90

 

 

1

3

5

Intraductal papilloma

 

7

9

 

 

10

 

 

5

3

5

ID + DCIS

X

15

40

18

15

40

20

15

1

3

4

Sclerosing adenosis

 

6

10

 

 

10

 

 

4

3

4

Papillary carcinoma

X

13

13

 

 

15

 

 

n/a

4

1

Follow up

 

19

0

 

 

 

 

 

1

4

5

ILC

 

20

30

 

 

28

 

 

0

4

2

Usual ductal hyperplasia

 

12

13

 

 

13

 

 

4

1

5

DCIS

X

No

25

16

9

22

15

7

3

3

5

Papillary carcinoma

 

20

25

 

 

24

 

 

5

5

5

IDC

 

25

25

 

 

25

 

 

5

5

5

IDC + DCIS

X

40

50

24

9

52

25

10

0

3

2

Follow-up

 

10

15

 

 

 

 

 

n/a

3

2

Follow-up

 

10

13

 

 

 

 

 

5

5

5

IDC

 

20

40

22

 

39

20

 

2

3

3

Papillomatosis

 

15

12

 

 

15

 

 

4

1

5

DCIS

X

no

35

 

 

35

 

 

3

3

4

Papillary carcinoma

 

25

25

12

 

25

10

 

4

4

3

Follow-up

 

13

15

 

 

 

 

 

n/a

3

2

Sclerosing adenosis

 

10

12

 

 

 

 

 

4

1

3

Follow-up

X

no

8

 

 

 

 

 

n/a

4

2

Follow-up

 

18

20

 

 

 

 

 

n/a

3

2

Follow-up

 

15

10

 

 

 

 

 

5

5

5

Multicentric IDC

 

12

35

26

10

30

30

10

n/a

4

3

Benign phyllodes tumour

 

40

40

 

 

43

 

 

n/a

4

2

Granulomatous mastitis

 

25

25

 

 

25

 

 

4

1

5

DCIS

X

0

30

 

 

38

 

 

4

4

3

Complex sclerosing lesion

 

22

23

 

 

23

 

 

4

4

5

IDC + ILC

 

22

35

 

 

38

 

 

n/a

3

2

Follow-up

 

7

7

 

 

 

 

 

3

1

3

Follow-up

 

no

10

6

 

 

 

 

3

3

3

Papilloma

 

5

5

 

 

5

 

 

n/a

3

4

IDC

 

15

10

 

 

11

 

 

0

3

4

IDC

 

21

45

23

 

45

24

 

n/a

3

4

Papillomatosis

 

6

8

 

 

8